Status:
COMPLETED
High Dose Intravenous Fish Oil Reduces Inflammation
Lead Sponsor:
Stanley Dudrick's Memorial Hospital
Conditions:
Lipid Metabolism Disorders
Eligibility:
All Genders
18+ years
Brief Summary
Retrospective analysis of 51 patients (27 female, 24 male, mean age 51.5±12.6 years) who received all-in-one PN including amino acids, glucose and lipids supplemented with pure fish oil LE was perform...
Detailed Description
All patients depended on parenteral nutrition (PN) are prone to inflammation. This condition may aggravate already existing proinflammatory status and can become a critical factor for developing liver...
Eligibility Criteria
Inclusion
- ≥ 18 years of age,
- metabolic stability (the absence of pathological laboratory resulting in the change of PN regime for at least one month)
- ability to tolerate up to 1.0 g lipids/kg body weight per day as a part of PN.
Exclusion
- patients with a history of cancer and anti-cancer treatment within the last 5 years, severe hyperlipidemia, severe coagulopathy, severe renal insufficiency, acute thromboembolic events, positive test for HIV, Hepatitis B or C (from medical history), known or suspected drug or alcohol abuse, participation in another interventional clinical trial in parallel or within three months prior to the start of this clinical trial, for women with childbearing potential (i.e. females who are not chemically or surgically sterile or females who are not postmenopausal) or women of childbearing potential tested positive on standard pregnancy test (urine dipstick) or/and lactation.
Key Trial Info
Start Date :
January 31 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04467138
Start Date
January 31 2020
End Date
June 30 2020
Last Update
July 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanley Dudrick's Memorial Hospital
Skawina, Poland, 32-050